Saturday, November 21, 2026

Moderna Stock Was Up By Over 20% Today

ViaNews Editorial Team

November 30, 2020

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Moderna Stock Was Up By Over 20%  Today

Moderna set to file for us, EU clearance for its coronavirus vaccine. According to today's article on ForexLive, "Moderna reaffirms that its vaccine is 94.1% effective in primary analysis - Vaccine was 94.1% effective in analysis of Phase 3 study, after 196 virus cases - Vaccine was 100% effective against strict virus cases in trial Another Monday, another dose of vaccine optimism to hit the market."

Moderna to ask FDA to authorize vaccine. According to today's article on The Wall Street Journal, "Moderna will ask U.S"

According to today's article on Bloomberg Quint, "Moderna Plans to Seek U.S., EU Clearance for Covid Vaccine."

Moderna to file EUA for coronavirus vaccine candidate, which previewed 94.1% efficacy. According to today's article on MarketWatch, "Moderna Inc"

According to today's article on MarketWatch, "Moderna shares soar 11% on filing for emergency-use authorization for vaccine."

Stocks making the biggest moves premarket: Moderna, IHS markit, slack & more. According to today's article on CNBC, "Some of the stocks posting the largest moves before the bell include Moderna, IHS Markit, Slack, and more.."

Stocks making the biggest moves premarket: Moderna, IHS markit, slack & more. According to today's article on CNBC, "Some of the stocks posting the largest moves before the bell include Moderna, IHS Markit, Slack, and more.."

Stocks making the biggest moves midday: Moderna, IHS markit, nikola, Carnival & more. According to today's article on CNBC, "Moderna shares rereport on strong efficacy data."

The Nasdaq Stock Market ended the session with Moderna jumping 20.24% to $152.74 on Monday while the The Nasdaq Stock Market slid 0.06% to $12,198.70.

Moderna today's close was $152.74, 1.15% under its 52-week high of $151.00.

Moderna's sales growth is 1425.2% for the present quarter and 9666.5% for the next. The company's growth estimates for the current quarter is a negative 48.6% and positive 437.1% for the next.

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna's stock is valued at $152.74 at 16:48 EST, higher than its 52-week high of $151.00.

Moderna's value is way higher than its 50-day moving average of $80.78 and way above its 200-day moving average of $70.99.

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 30 Nov 2020
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.